NPI: 1023313988 · LITTLE ROCK, AR 72205 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/24/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/24/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,649 | $215K |
| 2019 | 18,817 | $193K |
| 2020 | 19,933 | $218K |
| 2021 | 15,764 | $133K |
| 2022 | 10,495 | $100K |
| 2023 | 5,817 | $91K |
| 2024 | 2,641 | $53K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,675 | 1,783 | $231K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,489 | 2,307 | $177K |
| 83970 | 946 | 907 | $143K | |
| 82108 | 362 | 354 | $109K | |
| 82728 | 710 | 689 | $93K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,881 | 1,472 | $60K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 760 | 318 | $49K |
| A4657 | Syringe, with or without needle, each | 1,783 | 1,640 | $43K |
| 83550 | 685 | 668 | $35K | |
| 83540 | 688 | 669 | $30K | |
| 85041 | 1,292 | 1,190 | $14K | |
| 85048 | 1,283 | 1,184 | $11K | |
| J1756 | Injection, iron sucrose, 1 mg | 4,324 | 1,099 | $4K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,005 | 503 | $3K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 158 | 99 | $595.86 |
| 90674 | 33 | 33 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 42 | 42 | $0.00 |